Survival of AML patients relapsing after allogeneic hematopoietic cell transplantation: a CIBMTR study

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (alloHCT) remains a major therapeutic challenge. We studied outcomes of 1788 AML patients relapsing after alloHCT (1990–2010) during first or second complete remission (CR) to identify factors associated with lo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Bejanyan, Nelli, Weisdorf, Daniel J., Logan, Brent R., Wang, Hai-Lin, Devine, Steven M., de Lima, Marcos, Bunjes, Donald W., Zhang, Mei-Jie
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329076/
https://ncbi.nlm.nih.gov/pubmed/25460355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.11.007
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares